Unlocking the enigma of phenotypic drug tolerance: Mechanisms and emerging therapeutic strategies

Alok K Mishra1, Ritesh P Thakare1, Bela G Santani2

  • 1Division of Microbiology, CSIR-Central Drug Research Institute (CDRI), Jankipuram Extension, Lucknow, Uttar Pradesh, 226031, India; Department of Molecular Cell and Cancer Biology, UMass Chan Medical School, Worcester, MA, 01605, USA.

Biochimie
|January 3, 2024
PubMed

Insights

Microbial drug tolerance, a non-genetic survival strategy, complicates antimicrobial resistance. Understanding persistence mechanisms is key to developing new therapies for chronic and refractory infections.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Infectious Diseases

Background:

  • Antimicrobial resistance (AMR) is a major global health threat.
  • Phenotypic drug tolerance, distinct from genetic resistance, allows microbes to survive antibiotic exposure without mutations.
  • Persistence mechanisms are crucial for chronic and recurrent infections.

Purpose of the Study:

  • To comprehensively review microbial phenotypic drug tolerance and persister formation.
  • To explore the role of tolerance in acquired drug resistance.
  • To highlight emerging therapeutic strategies against persistent bacterial infections.

Main Methods:

  • Literature review of microbial persistence mechanisms.
  • Analysis of molecular pathways involved in drug tolerance.
  • Examination of therapeutic interventions for refractory infections.

Main Results:

  • Microbial populations utilize diverse strategies like dormancy, biofilms, and L-forms to achieve drug tolerance.
  • Key molecular mechanisms include toxin-antitoxin systems, oxidative stress responses, altered metabolism, and (p)ppGpp signaling.
  • Understanding these mechanisms is vital for predicting treatment outcomes and designing novel therapies.

Conclusions:

  • Phenotypic drug tolerance is a significant challenge in combating antimicrobial resistance.
  • Targeting persistence mechanisms offers a promising avenue for treating chronic and difficult-to-eradicate bacterial infections.
  • Further research into innovative therapeutic approaches is essential to overcome persistent bacterial infections.

Related Concept Videos

Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.7K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
479
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
625
Principles of Drug Action01:24

Principles of Drug Action

Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K